Neuralink plans to begin a US clinical trial in October to translate thoughts into text.
The study aims to assist people with speech impairments to communicate through thought. The company already has five other clinical trials ongoing worldwide. In the future, Neuralink envisions healthy individuals getting implants to communicate with AI models at the speed of thought.
Concerns have been raised about potential negative impacts of consumer brain implants and the influence of Elon Musk’s ideas on the technology’s development.
